Our Company
Our Company
Company Philosophy
Corporate Compliance
Management
Responsibility
Board of Directors
PRODUCTS
ROLVEDON
®
(eflapegrastim-xnst)
Development Pipeline
Pipeline
Poziotinib
Clinical Trials
Glossary
Investor Relations
Investor Relations
Press Releases
Events and Presentations
Corporate Governance
Corporate Governance
Management
Board of Directors
Committee Composition
Insider Transactions
Annual Report and Proxy Information
Financial Information
Financial Information
SEC Filings
10K Annual Reports
Quarterly Results
Financial Statements
Stock Information
Stock Information
Historic Stock Lookup
Investment Calculator
Stock-Split History
Analyst Coverage
Ownership Profile
Investor FAQs
Medical Affairs
Medical Affairs
Medical Information
Expanded Access Program
Careers
Contact Us
Committee Composition
Home
Investor Relations
Corporate Governance
Committee Composition
NASDAQ
SPPI
$1.03
+0.00
DAY HI:
$1.06
DAY LOW:
$0.97
VOLUME:
0
4:00 PM EST 07/31/23
Shareholder
Tools
Printed Materials
Email Alerts
Download Library
RSS Feeds
Committee Composition
Audit Committee
Nominating and Corporate Governance Committee
Compensation Committee
and Sustainability Committee
William L. Ashton
Brittany K. Bradrick
Seth H.Z. Fischer
Jeffrey L. Vacirca, MD, FACP
Juhyun Lim
= Chairman of the Board
= Chairperson
= Member